Generate Biomedicines, Inc. Common Stock (GENB) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · United States · ISIN US3709201004

Price
15.38 USD
Market cap
1.96 bn USD
P/E (2025)
–
P/S (2025)
61.46
Dividend yield
0.00 %
Net margin
-636.99 %
Return on equity (ROE)
–
Return on assets (ROA)
-61.53 %

Generate Biomedicines, Inc. Common Stock financials

Fiscal year20242025
Revenue20.46 m USD31.89 m USD
Gross profit20.46 m USD31.89 m USD
Operating income-196.94 m USD-235.07 m USD
EBIT-179.05 m USD-221.67 m USD
Net income-173.77 m USD-203.15 m USD
Diluted EPS – continuing operations-1.36 USD–

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Generate Biomedicines, Inc. Common Stock

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.